31/03/25 - General information
People with bronchiectasis, a chronic airway disease characterized by the accumulation of secretions in the bronchi leading to recurrent lung infections, are at high risk of experiencing a decline in muscle mass and function, known as sarcopenia. Having tools to diagnose their condition is vital to slowing its progression and avoiding a point of no return. For this reason, the Muscle Wasting and Cachexia in Chronic Respiratory Diseases and Lung Cancer Research Group of the Hospital del Mar Research Institute, together with the Pneumology and Radiology Services of Hospital del Mar and part of the dibi network, have conducted a study to validate the use of magnetic resonance imaging (MRI) to assess the muscular condition of these patients. The study is published in Archivos de Bronconeumología and also includes researchers from the CIBER Respiratory Diseases area (CIBERES).
25/03/2025 - General information
A new study led by researchers from the Hospital del Mar Research Institute and the Barcelonaβeta Brain Research Center (BBRC), the research centre of the Pasqual Maragall Foundation, has made significant strides in the search for effective blood-based biomarkers for Alzheimer's disease early detection. The research, published in the journal Alzheimer's & Dementia, provides a comprehensive comparison of various plasma biomarkers and their accuracy in detecting Alzheimer's disease in a memory clinic setting.
17/03/2025 - General information
The BAPP, a joint center between the Hospital del Mar Research Institute and Pompeu Fabra University, will maintain this quality seal from the Government of Catalonia until 2028. This recognition highlights its scientific and technical excellence, as well as its capacity for knowledge and technology transfer to the industry. The BioAnalysis, Proteomics and Pharmacology Center (BAPP), part of the Hospital del Mar Research Institute and Pompeu Fabra University, has renewed its TECNIO accreditation, awarded by the Government of Catalonia through ACCIÓ. This accreditation, valid until 2028, identifies and gives visibility to highly capable scientific and technical centers, recognized as developers of cutting-edge technologies and leaders in technology and knowledge transfer to the industry.
Més informació "The Hospital del Mar Research Institute renews the TECNIO accreditation"
24/02/25 - General information
Hospital del Mar and its research institute are part of this project, which aims to develop nanophotonic sensors for the diagnosis and clinical management of bacterial infections at the point of care. On February 14, Hospital del Mar hosted the fourth follow-up meeting of the PHITBAC project. This initiative is driven by a consortium with public and private participation to develop rapid tests for the swift detection of bacteria, their antibiotic resistance, and antibiotic levels in the blood, all based on nanophotonics. Rapid diagnosis of microorganisms that cause severe infections remains an unresolved challenge in infectious disease management, and immediate bedside monitoring of antibiotic levels in severe infections is an unmet need.
21/02/2025 - General information
Dr. Joaquim Gea, Emeritus Head of the Pulmonology Department and researcher at the Hospital del Mar Research Institute, has been appointed as the coordinator of two special issues of the journals Cells and International Journal of Molecular Science. His role will involve selecting both the topics and the authors of the articles to be featured in these issues.
11/02/25 - General information
At the Hospital del Mar Research Institute, every day we push science, medicine, and health forward. And we do it together. We are science, we are innovation, we are health. Professionals from all fields who research, care, create, and transform to advance knowledge and improve people's lives. We are the future. But we know there is still a long way to go. Science needs all perspectives, all voices, all talent. That's why today, we raise our voices. Because the world needs science, and science needs all of us. Today, we proudly celebrate the International Day of Women and Girls in Science, with commitment and the certainty that we are building a better future. Watch the video and share it!
07/02/25 - General information
The Hospital del Mar Research Institute and the company Bionure have signed an agreement to establish a strategic collaboration between the two institutions. The objective is the development of new RNA-based therapies for the treatment of neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS). The research center will be responsible for conducting proof-of-concept studies for potential medications, both in patient cells and in animal models, which is a necessary step before starting clinical trials in humans. RNA therapies for these types of pathologies are a promising tool not only to slow disease progression but also to potentially repair neuronal damage in neurodegenerative diseases with a genetic component.
12/12/2024 - General information
The SAGITTARIUS clinical trial has officially begun with the inclusion of the first six patients in the project. Among them, the first at the Hospital del Mar, a collaborating center in the study, which is coordinated in Spain by Dr. Clara Montagut, head of the Gastrointestinal Tumors section of the Medical Oncology Service and coordinator of the Colorectal Cancer Precision Medicine Research Group at the Hospital del Mar Research Institute.
Més informació "The SAGITTARIUS clinical trial, led by the Hospital del Mar in Spain, gets underway"
04/12/2024 - General information
She will hold the position for two years and will be responsible for reviewing and supervising the evaluation processes of each call within her field at the agency. Dr. Esther Barreiro, an associate physician in the Pulmonology Service at Hospital del Mar and a researcher at its research institute, has been appointed as the coordinator in the field of medical and health sciences at the Agency for the Management of University and Research Grants (AGAUR).
26/11/2024 - General information
They are included in the list of the 6,636 most cited researchers worldwide, compiled once again this year by the company. Two researchers from the Hospital del Mar Research Institute are once again among the most cited in the world, according to the Highly Cited Researcher ranking recently published by Clarivate Plc, a company specializing in bibliometrics, business intelligence, and market analysis. The researchers are Dr. Jordi Alonso and Dr. Joaquim Bellmunt, who have been recognized for the relevance of their published studies within their respective fields of expertise.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
